- Home
- MOMO vs NBTX Comparison
MOMO vs NBTX Comparison
Compare MOMO & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOMO
- NBTX
- Stock Information
- Founded
- MOMO 2011
- NBTX 2003
- Country
- MOMO China
- NBTX France
- Employees
- MOMO N/A
- NBTX N/A
- Industry
- MOMO Computer Software: Prepackaged Software
- NBTX Biotechnology: Pharmaceutical Preparations
- Sector
- MOMO Technology
- NBTX Health Care
- Exchange
- MOMO Nasdaq
- NBTX Nasdaq
- Market Cap
- MOMO 1.2B
- NBTX 1.3B
- IPO Year
- MOMO 2014
- NBTX 2020
- Fundamental
- Price
- MOMO $6.89
- NBTX $22.84
- Analyst Decision
- MOMO Buy
- NBTX Strong Buy
- Analyst Count
- MOMO 2
- NBTX 1
- Target Price
- MOMO $10.00
- NBTX $8.00
- AVG Volume (30 Days)
- MOMO 840.1K
- NBTX 133.2K
- Earning Date
- MOMO 12-08-2025
- NBTX 09-30-2025
- Dividend Yield
- MOMO 4.34%
- NBTX N/A
- EPS Growth
- MOMO N/A
- NBTX N/A
- EPS
- MOMO 0.68
- NBTX N/A
- Revenue
- MOMO $1,459,052,877.00
- NBTX $11,930,711.00
- Revenue This Year
- MOMO $0.62
- NBTX N/A
- Revenue Next Year
- MOMO $3.85
- NBTX $114.97
- P/E Ratio
- MOMO $10.22
- NBTX N/A
- Revenue Growth
- MOMO N/A
- NBTX N/A
- 52 Week Low
- MOMO $5.12
- NBTX $2.76
- 52 Week High
- MOMO $9.22
- NBTX $30.35
- Technical
- Relative Strength Index (RSI)
- MOMO 34.79
- NBTX 54.53
- Support Level
- MOMO $6.73
- NBTX $23.31
- Resistance Level
- MOMO $7.34
- NBTX $28.51
- Average True Range (ATR)
- MOMO 0.17
- NBTX 2.22
- MACD
- MOMO -0.01
- NBTX -0.45
- Stochastic Oscillator
- MOMO 16.85
- NBTX 33.54
About MOMO Hello Group Inc.
Hello Group Inc provides mobile-based social networking services. It enables users to establish and expand social relationships based on location and interests. Its platform includes the Momo mobile application and a variety of related features, functionalities, tools, and services that it provides to users, customers, and platform partners. The company derives its revenue from live video services, value-added services, mobile marketing services, mobile games, and other services. It operates in three segments: Momo's service lines, Tantan's service lines, and QOOL's service lines, out of which Momo's service lines segment derives the majority of revenue.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.